Your session is about to expire
← Back to Search
Online Physical Activity Program for Spinal Cord Injury (WOWii Trial)
WOWii Trial Summary
This trial is testing the feasibility, fidelity, and effectiveness of an online physical activity intervention for people with chronic SCI. The outcomes will measure enrollment, retention, engagement, and changes in exercise behavior and perceptions.
WOWii Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowWOWii Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.WOWii Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- It has been over a year since my spinal cord injury.I do not have cognitive or language issues affecting my participation.I use a wheelchair because of a spinal cord injury.
- Group 1: WOWii Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the research phase of this investigation still open to participants?
"Affirmative, the clinical trial is actively recruiting. As per records on clinicialtrials.gov, this research was initially posted in January 2nd 2022 and the latest update occurred on April 25th 2022. The study seeks 200 participants across two clinics."
What is the aggregate enrollment for this clinical trial?
"Affirmative. The specifications of this trial as published on clinicaltrials.gov show that the study is actively enrolling participants since its first posting date of February 1st, 2022 and last update on April 25th, 2022. 200 test subjects are needed from two separate sites for final results to be valid."
Share this study with friends
Copy Link
Messenger